584 related articles for article (PubMed ID: 27891750)
1. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of primary sclerosing cholangitis: an Australian non-transplant tertiary hospital perspective.
Freeman E; Majeed A; Kemp W; Roberts SK
Intern Med J; 2019 Mar; 49(3):323-327. PubMed ID: 30043518
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
[TBL] [Abstract][Full Text] [Related]
5. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
Nordenvall C; Olén O; Nilsson PJ; von Seth E; Ekbom A; Bottai M; Myrelid P; Bergquist A
Aliment Pharmacol Ther; 2018 Jan; 47(2):238-245. PubMed ID: 29064110
[TBL] [Abstract][Full Text] [Related]
6. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
7. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
Ngu JH; Gearry RB; Wright AJ; Stedman CA
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease.
Yanai H; Matalon S; Rosenblatt A; Awadie H; Berdichevski T; Snir Y; Kopylov U; Katz L; Stein A; Mlynarsky L; Tulchinsky H; Konikoff FM; Horin SB; Braun M; Ben-Ari Z; Chowers Y; Baruch Y; Shibolet O; Dotan I
J Crohns Colitis; 2015 Feb; 9(2):177-84. PubMed ID: 25518055
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
Bosch DE; Yeh MM
Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
[TBL] [Abstract][Full Text] [Related]
11. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
[TBL] [Abstract][Full Text] [Related]
12. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
[TBL] [Abstract][Full Text] [Related]
13. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
[TBL] [Abstract][Full Text] [Related]
15. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
16. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
[TBL] [Abstract][Full Text] [Related]
17. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ
Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study.
Lindström L; Jørgensen KK; Boberg KM; Castedal M; Rasmussen A; Rostved AA; Isoniemi H; Bottai M; Bergquist A
Scand J Gastroenterol; 2018 Mar; 53(3):297-304. PubMed ID: 29301479
[TBL] [Abstract][Full Text] [Related]
19. Systematic screening for primary sclerosing cholangitis with magnetic resonance cholangiography in inflammatory bowel disease.
Belle A; Laurent V; Pouillon L; Baumann C; Orry X; Lopez A; Rousseau H; Bronowicki JP; Peyrin-Biroulet L
Dig Liver Dis; 2018 Oct; 50(10):1012-1018. PubMed ID: 30076016
[TBL] [Abstract][Full Text] [Related]
20. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
